Business Standard

Wednesday, January 08, 2025 | 05:22 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Lupin receives USFDA approval for Fluoxetine Tablets

Image

Capital Market
Lupin has received approval for its Fluoxetine Tablets USP, 10 mg and 20 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Eli Lilly and Company's (Eli Lilly) Prozac Tablets, 10 mg and 20 mg.

Lupin's Fluoxetine Tablets USP, 10 mg and 20 mg, is the generic version of Eli Lilly's Prozac Tablets, 10 mg and 20 mg.

It is indicated in the treatment of Major Depressive Disorder, bsessive Compulsive Disorder, Bulimia Nervosa and Panic Disorder.

Fluoxetine Tablets, 10 mg and 20 mg, (RLD: Prozac) had annual sales of approximately USD 68.2 million in the US (IQVIA MAT December 2018).

 

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 16 2019 | 2:16 PM IST

Explore News